litlas
Log inCreate account

Peter Calverley

Active 1983–2022

38
Papers
23,521
Citations
37
h-index
38
i10-index

Citations

Citations per year for Peter Calverley1975: 1 citations1985: 7 citations1986: 4 citations1987: 3 citations1988: 9 citations1989: 10 citations1990: 6 citations1991: 5 citations1992: 7 citations1993: 4 citations1994: 12 citations1995: 10 citations1996: 12 citations1997: 9 citations1998: 10 citations1999: 11 citations2000: 12 citations2001: 19 citations2002: 58 citations2003: 126 citations2004: 126 citations2005: 191 citations2006: 228 citations2007: 222 citations2008: 224 citations2009: 226 citations2010: 218 citations2011: 199 citations2012: 209 citations2013: 190 citations2014: 172 citations2015: 174 citations2016: 137 citations2017: 138 citations2018: 103 citations2019: 451 citations2020: 383 citations2021: 289 citations2022: 228 citations2023: 173 citations2024: 330 citations2025: 121 citations2026: 1 citations1976–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,564 citing papers, 18.1% of this breakdownUnited Kingdom: 1,031 citing papers, 11.9% of this breakdownCanada: 493 citing papers, 5.7% of this breakdownItaly: 447 citing papers, 5.2% of this breakdownSpain: 415 citing papers, 4.8% of this breakdownNetherlands: 387 citing papers, 4.5% of this breakdownChina: 364 citing papers, 4.2% of this breakdownGermany: 363 citing papers, 4.2% of this breakdownAustralia: 351 citing papers, 4.1% of this breakdownFrance: 270 citing papers, 3.1% of this breakdownBelgium: 240 citing papers, 2.8% of this breakdownSweden: 219 citing papers, 2.5% of this breakdown
0%18.1%Other 28.9%

Institutions

Fields

  • Medicine84.4%
  • Biochemistry, Genetics and Molecular Biology6.5%
  • Environmental Science1.4%
  • Immunology and Microbiology1.3%
  • Health Professions1.2%
  • Neuroscience1.1%
  • Other4.1%

Topics

  • Chronic Obstructive Pulmonary Disease (COPD) Research23.8%
  • Respiratory Support and Mechanisms9.1%
  • Asthma and respiratory diseases9%
  • Respiratory and Cough-Related Research3.6%
  • Delphi Technique in Research2.9%
  • Inhalation and Respiratory Drug Delivery2.5%
  • Other49.1%

Coauthors

All papers

Open in search
  1. The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress

    Authors: Ganesh Raghu, Michael Berk, Peter A. Campochiaro, Hartmut Jaeschke, Giancarlo Marenzi, Luca Richeldi, Fuqiang Wen, Ferdinando Nicoletti, Peter Calverley - Current Neuropharmacology 2020 cited by 273

  2. An Official American Thoracic Society Statement: Update on the Mechanisms, Assessment, and Management of Dyspnea

    Authors: Mark B. Parshall, Richard M. Schwartzstein, Lewis Adams, Robert B. Banzett, Harold L. Manning, Jean Bourbeau, Peter Calverley, Audrey G. Gift, Andrew Harver, Suzanne C. Lareau, Donald A. Mahler, Paula Meek, Denis E. O’Donnell - American Journal of Respiratory and Critical Care Medicine 2012 cited by 1,835

  3. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

    Authors: Romain Pauwels, A. Sonia Buist, Peter Calverley, Christine Jenkins, Suzanne S. Hurd - American Journal of Respiratory and Critical Care Medicine 2001 cited by 6,595

  4. Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre–Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward

    Authors: Fernando J. Martinez, Fernando J. Martinez, Alvar Agusti, Bartolome R. Celli, MeiLan K. Han, James P. Allinson, Surya P. Bhatt, Peter Calverley, Sanjay H. Chotirmall, Badrul Chowdhury, Patrick Darken, Carla A. Da Silva, Gavin Donaldson, Paul Dorinsky, Mark Dransfield, Rosa Faner, David M. Halpin, Paul Jones, Jerry A. Krishnan, Nicholas Locantore, Fernando D. Martinez, Fernando D. Martinez, Hana Mullerova, David Price, Klaus F. Rabe, Colin Reisner, Dave Singh, Jørgen Vestbo, Claus F. Vogelmeier, Robert A. Wise, Ruth Tal-Singer, Jadwiga A. Wedzicha - American Journal of Respiratory and Critical Care Medicine 2021 cited by 160

  5. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

    Authors: Bartolomé R. Celli, William MacNee, Àlvar Agustí, Antonio Anzueto, Benjamin W. Berg, A. Sonia Buist, Peter Calverley, Niels H. Chavannes, Thomas A. Dillard, Bonnie Fahy, Alan M. Fein, John E. Heffner, SUZANNE C. LAREAU, Paula Meek, Fernando J. Martínez, Walter T. McNicholas, Jean Muris, Elise Lynn Austegard, Ruben Pauwels, Stephen I. Rennard, Andrea Rossi, N. Siafakas, Brian Tiep, Jørgen Vestbo, Emiel F.�M. Wouters, Richard ZuWallack - European Respiratory Journal 2004 cited by 4,434

  6. openalex_id:w4225837250

    Authors: Fernando J. Martínez, Àlvar Agustí, Bartolomé R. Celli, MeiLan K. Han, James P. Allinson, Surya P. Bhatt, Peter Calverley, Sanjay H. Chotirmall, Badrul A. Chowdhury, Patrick Darken, Carla A. Da Silva, Gavin C. Donaldson, Paul Dorinsky, Mark T. Dransfield, Rosa Faner, David Halpin, Paul Jones, Jerry A. Krishnan, Nicholas Locantore, Fernando D. Martínez, Hana Müllerová, David Price, Klaus F. Rabe, Colin Reisner, Dave Singh, Jørgen Vestbo, Claus Vogelmeier, Robert A. Wise, Ruth Tal‐Singer cited by 130

  7. Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease

    Authors: Peter Calverley, Julie A. Anderson, Bartolomé R. Celli, Gary T. Ferguson, Christine Jenkins, Paul Jones, Julie Yates, Jørgen Vestbo - New England Journal of Medicine 2007 cited by 3,258

  8. Outcomes for COPD pharmacological trials: from lung function to biomarkers

    Authors: Mario Cazzola, William MacNee, Fernando J. Martínez, Klaus F. Rabe, Luigi G. Franciosi, Peter J. Barnes, Vito Brusasco, P. S. Burge, Peter Calverley, Bartolomé R. Celli, Paul Jones, Donald A. Mahler, Barry J. Make, Marc Miravitlles, Clive Page, Paolo Palange, David Parr, M. Pistolesi, Stephen I. Rennard, Maureen Rutten‐van Mölken, Robert A. Stockley, SD Sullivan, Jadwiga A. Wedzicha, Emiel F.�M. Wouters - European Respiratory Journal 2008 cited by 857

  9. Detection of expiratory flow limitation in COPD using the forced oscillation technique

    Authors: Raffaele L. Dellacá, Pierachille Santus, Andréa Aliverti, N. Stevenson, Stefano Centanni, Peter T. Macklem, A. Pedotti, Peter Calverley - European Respiratory Journal 2004 cited by 354

  10. Safety of N-Acetylcysteine at High Doses in Chronic Respiratory Diseases: A Review

    Authors: Peter Calverley, Paola Rogliani, Alberto Papi - Drug Safety 2020 cited by 75

  11. Changes in Spirometry Over Time as a Prognostic Marker in Patients with Duchenne Muscular Dystrophy

    Authors: Margaret Phillips, Rosaline C. M. Quinlivan, R. H. T. Edwards, Peter Calverley - American Journal of Respiratory and Critical Care Medicine 2001 cited by 283

  12. Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study

    Authors: Christine Jenkins, Bartolomé R. Celli, Julie A. Anderson, Gary T. Ferguson, Peter M. Jones, Jørgen Vestbo, Julie Yates, Peter Calverley - European Respiratory Journal 2011 cited by 235

  13. Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results

    Authors: Courtney Crim, Peter Calverley, Julie A. Anderson, Bartolomé R. Celli, Gary T. Ferguson, Christine Jenkins, Paul Jones, Lisa Willits, Julie Yates, Jørgen Vestbo - European Respiratory Journal 2009 cited by 438

  14. Roflumilast: a review of its use in the treatment of COPD

    Authors: Jadwiga Wedzicha, Peter Calverley, Klaus Rabe - International Journal of COPD 2016 cited by 166

  15. Cystic Fibrosis Transmembrane Conductance Regulator: Roles in Chronic Obstructive Pulmonary Disease

    Authors: Mark Dransfield, Steven Rowe, Claus F. Vogelmeier, Jadwiga Wedzicha, Gerard J. Criner, MeiLan K. Han, Fernando J. Martinez, Peter Calverley - American Journal of Respiratory and Critical Care Medicine 2022 cited by 33

  16. Effect of Carbon Dioxide on Diaphragmatic Function in Human Beings

    Authors: Gustavo Alberto San Juan, Peter Calverley, Carlos Tálamo, Jeff Schnader, Charis Roussos - New England Journal of Medicine 1984 cited by 329

  17. An official American Thoracic Society/European Respiratory Society statement: research questions in COPD

    Authors: Bartolomé R. Celli, Marc Decramer, Jadwiga A. Wedzicha, Kevin C. Wilson, Àlvar Agustí, Gerard J. Criner, William MacNee, Barry J. Make, Stephen I. Rennard, Robert A. Stockley, Claus Vogelmeier, Antonio Anzueto, David H. Au, Peter J. Barnes, Pierre‐Régis Burgel, Peter Calverley, Ciro Casanova, Enrico Clini, Christopher B. Cooper, Harvey O. Coxson, Daniel Dusser, Leonardo M. Fabbri, Bonnie Fahy, Gary T. Ferguson, Andrew J. Fisher, Monica Fletcher, Maurice Hayot, John R. Hurst, Paul Jones, Donald A. Mahler, François Maltais, David M. Mannino, Fernando J. Martínez, Marc Miravitlles, Paula Meek, Alberto Papi, Klaus F. Rabe, Nicolás Roche, Frank C. Sciurba, Sanjay Sethi, Nikos M. Siafakas, Don D. Sin, Joan B. Soriano, James K. Stoller, Donald P. Tashkin, Thierry Troosters, Geert M. Verleden, Johny Verschakelen, Jørgen Vestbo, John W. Walsh, George R. Washko, Robert A. Wise, Emiel F.�M. Wouters, Richard ZuWallack - European Respiratory Journal 2015 cited by 203

  18. Expiratory flow limitation detected by forced oscillation and negative expiratory pressure

    Authors: Raffaele L. Dellacá, Nick Duffy, Pasquale Pio Pompilio, Andréa Aliverti, Νikolaos Koulouris, A. Pedotti, Peter Calverley - European Respiratory Journal 2006 cited by 141

  19. Function of Pulmonary Neuronal M2 Muscarinic Receptors in Stable Chronic Obstructive Pulmonary Disease

    Authors: LING SAI ON, Petchara Boonyongsunchai, Samantha Webb, Lisa Davies, Peter Calverley, Richard W. Costello - American Journal of Respiratory and Critical Care Medicine 2001 cited by 82

  20. Tiotropium Respimat Inhaler and the Risk of Death in COPD

    Authors: Robert A. Wise, Antonio Anzueto, Daniel Cotton, Ronald Dahl, Theresa Devins, Bernd Disse, Daniel Dusser, Elizabeth Joseph, Sabine Kattenbeck, Michael Koenen‐Bergmann, Gordon Pledger, Peter Calverley - New England Journal of Medicine 2013 cited by 334

  21. Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology

    Authors: Peter Calverley, Νikolaos Koulouris - European Respiratory Journal 2005 cited by 259

  22. An Official American Thoracic Society/European Respiratory Society Statement: Research Questions in Chronic Obstructive Pulmonary Disease

    Authors: Bartolomé R. Celli, Marc Decramer, Jadwiga A. Wedzicha, Kevin C. Wilson, Àlvar Agustí, Gerard J. Criner, William MacNee, Barry J. Make, Stephen I. Rennard, Robert A. Stockley, Claus Vogelmeier, Antonio Anzueto, David H. Au, Peter J. Barnes, Pierre‐Régis Burgel, Peter Calverley, Ciro Casanova, Enrico Clini, Christopher B. Cooper, Harvey O. Coxson, Daniel Dusser, Leonardo M. Fabbri, Bonnie Fahy, Gary T. Ferguson, Andrew J. Fisher, Monica Fletcher, Maurice Hayot, John R. Hurst, Paul Jones, Donald A. Mahler, François Maltais, David M. Mannino, Fernando J. Martínez, Marc Miravitlles, Paula Meek, Alberto Papi, Klaus F. Rabe, Nicolás Roche, Frank C. Sciurba, Sanjay Sethi, Nikos M. Siafakas, Don D. Sin, Joan B. Soriano, James K. Stoller, Donald P. Tashkin, Thierry Troosters, Geert M. Verleden, Johny Verschakelen, Jørgen Vestbo, John W. Walsh, George R. Washko, Robert A. Wise, Emiel F.�M. Wouters, Richard ZuWallack - American Journal of Respiratory and Critical Care Medicine 2015 cited by 217

  23. Hypoxemia during Sleep in Duchenne Muscular Dystrophy

    Authors: Phil E M Smith, Peter Calverley, R. H. T. Edwards - American Review of Respiratory Disease 1988 cited by 187

  24. Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis

    Authors: Mona Bafadhel, Lisa Davies, Peter Calverley, Shawn D. Aaron, Christopher E. Brightling, Ian Pavord - European Respiratory Journal 2014 cited by 169